Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
Coherus Oncology, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Delfi Diagnostics Inc.
Novita Pharmaceuticals, Inc.
Celldex Therapeutics
Istanbul Saglik Bilimleri University
Taproot Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DxTerity Diagnostics
VA Office of Research and Development
Xencor, Inc.
Celldex Therapeutics
Children's Oncology Group
Klus Pharma Inc.
Celldex Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Exact Sciences Corporation
Pfizer
Novartis
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Zhujiang Hospital
University of Zurich
University of Chicago
Ipsen
Stanford University
Butler Hospital
University of Kansas Medical Center
Duke University
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Santa Maria Biotherapeutics
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Children's Oncology Group
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Uppsala University Hospital
Duke University
AEterna Zentaris
Children's Oncology Group